Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tilman Todenhöfer

Showing results (1-10 of 168) with videos related to

Pageof 17
Sort By:
Der Urologe. Ausg. A|April 6, 2020
[Chemotherapy provides improved outcomes compared to novel hormonal therapy : Optimal treatment sequence after failure of abiraterone or enzalutamide]Tilman Todenhöfer
The Journal of Urology|April 29, 2020
Editorial CommentTilman Todenhöfer
The Journal of Urology|October 4, 2019
Editorial CommentTilman Todenhöfer
Translational Andrology and Urology|November 22, 2021
Preface to "Management of advanced genitourinary malignancies"Tilman Todenhöfer
International Journal of Urology : Official Journal of the Japanese Urological Association|April 5, 2016
Editorial Comment to Robotic transmural ablation of bladder tumors using high-intensity focused ultrasound: Experimental studyTilman Todenhöfer, Roland Seiler
European Urology Focus|November 29, 2018
Are There Still Patients with Metastatic Hormone-sensitive Prostate Cancer Who Should Be Treated with Androgen Deprivation Monotherapy?Alexander Kretschmer, Tilman Todenhöfer
Translational Andrology and Urology|August 9, 2019
Molecular subtypes and response to immunotherapy in bladder cancer patientsTilman Todenhöfer, Roland Seiler
International Journal of Urology : Official Journal of the Japanese Urological Association|June 21, 2014
Editorial comment from Dr Todenhöfer and Dr Schwentner to recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular gradingTilman Todenhöfer, Christian Schwentner
European Urology|December 26, 2019
Re: Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate CancerTilman Todenhöfer, Christian Gratzke
Der Urologe. Ausg. A|November 17, 2020
[Systemic treatment of advanced prostate cancer]Alexander Kretschmer, Tilman Todenhöfer
Pageof 17

Showing results (1-10 of 168) with videos related to

Sort By:
Pageof 17
Der Urologe. Ausg. A|April 6, 2020
[Chemotherapy provides improved outcomes compared to novel hormonal therapy : Optimal treatment sequence after failure of abiraterone or enzalutamide]Tilman Todenhöfer
The Journal of Urology|April 29, 2020
Editorial CommentTilman Todenhöfer
The Journal of Urology|October 4, 2019
Editorial CommentTilman Todenhöfer
Translational Andrology and Urology|November 22, 2021
Preface to "Management of advanced genitourinary malignancies"Tilman Todenhöfer
International Journal of Urology : Official Journal of the Japanese Urological Association|April 5, 2016
Editorial Comment to Robotic transmural ablation of bladder tumors using high-intensity focused ultrasound: Experimental studyTilman Todenhöfer, Roland Seiler
European Urology Focus|November 29, 2018
Are There Still Patients with Metastatic Hormone-sensitive Prostate Cancer Who Should Be Treated with Androgen Deprivation Monotherapy?Alexander Kretschmer, Tilman Todenhöfer
Translational Andrology and Urology|August 9, 2019
Molecular subtypes and response to immunotherapy in bladder cancer patientsTilman Todenhöfer, Roland Seiler
International Journal of Urology : Official Journal of the Japanese Urological Association|June 21, 2014
Editorial comment from Dr Todenhöfer and Dr Schwentner to recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular gradingTilman Todenhöfer, Christian Schwentner
European Urology|December 26, 2019
Re: Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate CancerTilman Todenhöfer, Christian Gratzke
Der Urologe. Ausg. A|November 17, 2020
[Systemic treatment of advanced prostate cancer]Alexander Kretschmer, Tilman Todenhöfer
Pageof 17